(Baothanhhoa.vn) - Hiện BA.5, biến thể phụ của Omicron, đã trở thành biến thể lây nhiễm chủ đạo tại Mỹ và khiến làn sóng dịch COVID-19 trỗi dậy ở một số nước châu Âu.
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
Lan Phương (TTXVN/Vietnam+)
Từ khóa:
Trung tâm
Châu Âu
Mỹ
Vaccine
Nhân viên y tế
Phòng chống dịch bệnh
Người đứng đầu
Tiêm chủng
Phòng chống dịch
Lây nhiễm
Nhập viện điều trị
{name} - {time}
{body}
{name} - {time}
{body}
Ý kiến của bạn sẽ được biên tập trước khi đăng. Vui lòng gõ tiếng Việt có dấu
-
2023-05-20 16:50:00Chuẩn bị hồ sơ trình Thủ tướng xem xét công bố hết dịch COVID-19
-
2023-04-20 09:10:00WHO và Bộ Y tế khuyến cáo người dân Việt Nam tăng cường phòng dịch trong kỳ nghỉ lễ
-
2022-07-15 22:55:00Kiểm soát không để dịch COVID-19 bùng phát trở lại
Ngày 15-7, Thanh Hoá ghi nhận 25 bệnh nhân mắc COVID-19
Ngày 14-7, Thanh Hóa ghi nhận 46 bệnh nhân mắc COVID-19
Ngày 13-7, Thanh Hoá ghi nhận 33 bệnh nhân mắc COVID-19
Người đã mắc biến thể BA.1, BA.2 vẫn có thể mắc lại BA.4, BA.5
Ngày 12-7, Thanh Hoá ghi nhận 29 bệnh nhân mắc COVID-19
Ngăn ngừa nhiễm biến thể phụ BA.5 - vaccine vẫn là “vũ khí” hàng đầu
Ngày 11-7, Thanh Hóa ghi nhận 17 bệnh nhân mắc COVID-19
Ngày 10-7, Thanh Hoá ghi nhận 21 bệnh nhân mắc COVID-19
Ngày 9-7, Thanh Hoá ghi nhận 19 bệnh nhân mắc COVID-19
Địa phương
Thời tiết
Bình luận
